Mouth sores caused by cancer treatment: How to copeUnderstand how to manage cancer treatment side effects, including mouth sores, so that you can feel more in control as you go through cancer treatment.
By Mayo Clinic Staff
If you're about to begin cancer treatment, be aware that certain treatments can cause mouth sores (oral mucositis). Mouth sores can be painful and distressing. They can range from a mere inconvenience to a severe complication that may make you unable to continue your cancer treatment.
What are cancer-related mouth sores?
Cancer-related mouth sores are sores or ulcers that form on the inside lining of your mouth or on your lips. The mouth sores appear burn-like and can be painful, making it difficult to eat, talk, swallow and breathe. Sores can appear on any of the soft tissues of your lips or your mouth, including your gums, your tongue, or the roof and floor of your mouth. Sores can also extend into the tube (esophagus) that carries food to your stomach.
How do cancer treatments cause mouth sores?
Chemotherapy and radiation — alone or combined — can cause mouth sores. That's because these cancer treatments are intended to kill rapidly growing cells — such as cancer cells. Some healthy cells in your body also divide and grow rapidly, including the cells that line the inside of your mouth. Unfortunately these healthy cells are also damaged by chemotherapy and radiation. Damage to the cells in your mouth makes it difficult for your mouth to heal itself and to fend off germs, leading to sores and infections.
Chemotherapy and radiation both can impair your body's germ-fighting system (immune system). With an impaired immune system, viruses, bacteria and fungi can more easily infect your mouth, causing mouth sores or making mouth sores worse.
Bone marrow or stem cell transplants also can lead to mouth sores if you develop graft-versus-host disease (GVHD). In GVHD the transplanted cells or stem cells try to reject your body's normal cells. The transplanted cells view your body's cells as foreign and attack them. Mouth sores are just one sign of GVHD.
Here's what you may experience with each type of cancer treatment.
Whether you experience mouth sores while undergoing chemotherapy depends on the type and dose of medication you receive, as well as how often you receive your treatment. The chemotherapy drugs most likely to cause mouth sores include:
- Capecitabine (Xeloda)
- Cytarabine (Cytosar-U)
- Doxorubicin (Adriamycin, Doxil)
- Methotrexate (Rheumatrex, Trexall)
Mouth sores caused by chemotherapy treatment usually develop a few days after treatment begins and go away within two or three weeks after stopping chemotherapy. The mouth sores usually reach their peak around the seventh day after chemotherapy treatment ends.
Head or neck radiation therapy
Only radiation aimed at your head or neck causes mouth sores. Whether your radiation treatment will cause mouth sores depends on how much radiation you receive and whether you're also receiving chemotherapy at the same time. You may begin to experience mouth pain two to three weeks after you begin radiation. More-intense doses of radiation will cause mouth sores to develop more quickly. Mouth sores from radiation may last four to six weeks after your last radiation treatment.
Bone marrow or stem cell transplant
Aug. 20, 2011
Mouth sores associated with GVHD develop two to three weeks after a bone marrow or stem cell transplant. People who receive transplants usually receive high-dose chemotherapy or radiation to prepare their bodies for the transplant. Since these therapies also cause mouth sores, it can be difficult to tell whether the sores are from the transplant preparation treatment or from GVHD. Your doctor may test cells from your mouth to determine what's causing your mouth sores.
See more In-depth
- Sideras K, et al. Oral complications. In: Abeloff MD, et al. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa.: Churchill Livingstone; 2008:609.
- Oral complications of chemotherapy and head/neck radiation (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/supportivecare/oralcomplications/Patient/AllPages. Accessed June 13, 2011.
- Worthington HV, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment (review). Cochrane Database of Systematic Reviews. 2011;CD000978. http://www2.cochrane.org/reviews. Accessed June 13, 2011.
- Kepivance (prescribing information). Thousand Oaks, Calif.: Amgen; 2005. http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/125103s0010lbl.pdf. Accessed June 13, 2011.
- Xeloda (prescribing information). South San Francisco, Calif.: Genentech; 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020896s026lbl.pdf. Accessed June 13, 2011.
- Moynihan TJ (expert opinion). Mayo Clinic, Rochester, Minn. July 8, 2011.